PURPOSE: The aim of this study is to overcome tumour cell resistance that generally develops after administration of commonly used anti-cancer drugs, such as doxorubicin. METHODS: Recently, cell penetrating peptides have been used for their ability to deliver non-permeant compounds into cells. One such cell penetrating peptide, maurocalcine, has been isolated from the venom of a Tunisian scorpion. Herein, we report the effects of doxorubicin covalently coupled to an analogue of maurocalcine on drug-sensitive or drug-resistant cell lines MCF7 and MDA-MB 231. RESULTS: We demonstrated the in vitro anti-tumoral efficacy of the doxorubicin maurocalcine conjugate. On a doxorubicin-sensitive cancer cell line, the maurocalcine-conjugated form appears slightly less efficient than doxorubicin itself. On the contrary, on a doxorubicin-resistant cancer cell line, doxorubicin coupling allows to overcome the drug resistance. This strategy can be generalized to other cell penetrating peptides since Tat and penetratin show similar effects. CONCLUSION: We conclude that coupling anti-tumoral drugs to cell penetrating peptides represent a valuable strategy to overcome drug resistance.
PURPOSE: The aim of this study is to overcome tumour cell resistance that generally develops after administration of commonly used anti-cancer drugs, such as doxorubicin. METHODS: Recently, cell penetrating peptides have been used for their ability to deliver non-permeant compounds into cells. One such cell penetrating peptide, maurocalcine, has been isolated from the venom of a Tunisian scorpion. Herein, we report the effects of doxorubicin covalently coupled to an analogue of maurocalcine on drug-sensitive or drug-resistant cell lines MCF7 and MDA-MB 231. RESULTS: We demonstrated the in vitro anti-tumoral efficacy of the doxorubicin maurocalcine conjugate. On a doxorubicin-sensitive cancer cell line, the maurocalcine-conjugated form appears slightly less efficient than doxorubicin itself. On the contrary, on a doxorubicin-resistant cancer cell line, doxorubicin coupling allows to overcome the drug resistance. This strategy can be generalized to other cell penetrating peptides since Tat and penetratin show similar effects. CONCLUSION: We conclude that coupling anti-tumoral drugs to cell penetrating peptides represent a valuable strategy to overcome drug resistance.
Authors: Laura Smith; Mark B Watson; Sara L O'Kane; Philip J Drew; Michael J Lind; Lynn Cawkwell Journal: Mol Cancer Ther Date: 2006-08 Impact factor: 6.261
Authors: Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman Journal: Nat Rev Drug Discov Date: 2006-03 Impact factor: 84.694
Authors: Amy Wu; Kevin Loutherback; Guillaume Lambert; Luis Estévez-Salmerón; Thea D Tlsty; Robert H Austin; James C Sturm Journal: Proc Natl Acad Sci U S A Date: 2013-09-17 Impact factor: 11.205
Authors: Ashwath Jayagopal; Yan Ru Su; John L Blakemore; MacRae F Linton; Sergio Fazio; Frederick R Haselton Journal: Nanotechnology Date: 2009-03-31 Impact factor: 3.874
Authors: Michel Ronjat; Wei Feng; Lucie Dardevet; Yao Dong; Sawsan Al Khoury; Franck C Chatelain; Virginie Vialla; Samir Chahboun; Florian Lesage; Hervé Darbon; Isaac N Pessah; Michel De Waard Journal: Proc Natl Acad Sci U S A Date: 2016-04-11 Impact factor: 11.205